How Do You Sign Up for the Medicare GLP-1 Bridge?

The thing to understand up front is that there is no sign-up form, no separate enrollment window, and no application you fill out yourself. Access to the Medicare GLP-1 Bridge runs through your prescriber and your existing drug plan. If you have qualifying Medicare drug coverage and you meet the clinical criteria, your prescriber submits a prior authorization, attests that you met the requirements at the start of treatment, and the covered medication is then dispensed at the flat $50 monthly copay. Your job is to have the right coverage in place and the right documentation ready. Here’s how it actually works, step by step.

Step one: confirm you have the right coverage

The Bridge attaches to Medicare drug coverage, so you need either a standalone Part D plan or a Medicare Advantage plan that includes drug coverage. If you have Original Medicare without a drug plan, there’s nothing for the Bridge to connect to, and the first move is enrolling in drug coverage during an appropriate enrollment period. This is the part you control directly, and it’s worth checking before anything else.

Step two: have the clinical documentation ready

Because eligibility is assessed at the start of GLP-1 treatment and your prescriber has to attest to it, the documentation matters. You’ll want your BMI at initiation and any qualifying conditions clearly in your record: heart failure, uncontrolled hypertension, chronic kidney disease, prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease, depending on which tier you fall into.

Consider a scenario where someone knows they had a BMI of 36 when they first started a GLP-1, but it isn’t clearly noted in their current chart. Getting that documented before the prior authorization goes in can prevent a back-and-forth that delays the first fill.

Step three: the prescriber submits the prior authorization

This is the actual mechanism. Your prescriber submits a prior authorization for the covered medication and attests that you met the BMI and condition criteria when treatment began. Humana serves as the central processor for the program, handling authorizations, claims, and pharmacy payment across plans. Once the authorization clears, the pharmacy dispenses the medication at $50.

There’s no parallel form for you to submit. If a website or service tells you to “apply for the Bridge” through them, treat that with caution, because the legitimate path is a clinical prior authorization, not a consumer sign-up.

Step four: make sure you’re prescribed a covered formulation

The Bridge covers specific products: Wegovy in all its forms, Foundayo, and the Zepbound KwikPen. It does not cover Zepbound vials or single-dose pens. So part of getting access smoothly is making sure the prescription is written for a covered formulation. Consider a scenario where someone asks for Zepbound expecting the $50 copay, but the prescription is written for vials. The Bridge won’t apply to that format, and they’d need the KwikPen instead to use the copay.

What can slow you down

A few things commonly cause delays. Missing or unclear documentation of your starting BMI is the big one. Being prescribed a non-covered formulation is another. And a mismatch between your coverage type and the program (for example, assuming Original Medicare alone is enough) will stop the process before it starts. None of these are hard to fix, but they’re easier to fix before the prior authorization than after a denial.

A realistic timeline expectation

Prior authorizations take time to process, and the exact turnaround varies. Build in a buffer rather than assuming same-week access, especially for a first fill where documentation may need to be assembled. If you’re transitioning from another route, don’t let your current supply run to zero while the authorization is pending.

Why it’s worth getting on the right medication

The administrative steps are only worth it because the medication works, and the data behind these drugs in older adults is solid. In the SUSTAIN 4 trial, once-weekly semaglutide was compared against insulin glargine in insulin-naive adults with type 2 diabetes across 196 sites in 14 countries, and semaglutide lowered A1c more while reducing body weight, whereas the insulin comparator tended to add weight. For the Medicare-aged population the Bridge serves, that combination of glucose control and weight reduction is exactly the point, which makes the paperwork worth pushing through.

If the Bridge path stalls or doesn’t apply

If you don’t have qualifying coverage, don’t meet the criteria, or simply don’t want to wait on prior authorizations, there’s a route with no insurance machinery at all. TrimRx connects you with licensed providers who prescribe semaglutide or tirzepatide when it’s clinically appropriate, and it bundles the provider visit and shipping into a flat monthly structure with no insurance required, across a program range of $179 to $1,579 depending on the medication and plan. No prior authorization, no attestation, no enrollment window.

If you want to compare the Bridge process against a cash-pay program for your situation, the free assessment quiz is a fast first step.

This article is for general information and is not medical or insurance advice. The Medicare GLP-1 Bridge is administered by CMS and participating plans, and its processes can change. Confirm current requirements with Medicare, your plan, and your prescriber.